Molecular genetic basis of Gilbert's syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 10, 1999, Pages 960-966

  Burchell, B ^a   Hume, R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Breast milk; Drug toxicity; Genetic analysis; Glucuronidation; Jaundice; Neonates; Population studies

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE; URIDINE DIPHOSPHATE;

ARTICLE; BILIRUBIN BLOOD LEVEL; DNA POLYMORPHISM; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GILBERT DISEASE; HUMAN; LIVER FUNCTION; NEWBORN JAUNDICE; PRIORITY JOURNAL; TATA BOX;

EID: 0032847365     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01984.x     Document Type: Article

References (47)

1. Watson KJR, Gollan JL. Gilbert's syndrome. Balliere's Clin. Gastroenterol. 1989; 3: 337-55.
2. Lascelles PT, Donaldson D. Calorie restriction test. In: Lascelles PT, Donaldson D, eds. Diagnostic Function Tests in Chemical Pathology. Lancaster: Kluwer, 1989; 24-5.
3. Jedlitschky G, Leier I, Bucholz U, Hummel-Eisenbeiss J, Burchell B, Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 1997; 327: 291-6.
4. Clarke DJ, Moghrabi N, Monaghan G, Cassidy A, Boxer M, Burchell B. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. Clin. Chim. Acta 1997; 266: 63-74.
5. Burchell B, Brierley CH, Monaghan G, Clarke DJ. The structure and function of the UDP-glucuronosyltransferase gene family. Adv. Pharmacol. 1997; 42: 335-8.
6. Ritter JK, Chen F, Sheen YY et al. A novel complex locus UGT-1 encodes human bilirubin, phenol and other UDP-glucuronosyltransferase isoenzymes with identical carboxyl termini. J. Biol. Chem. 1992; 267: 3257-61.
7. Brierley CH, Bin Senafi S, Clarke DJ, Hsu M-H, Johnson EF, Burchell B. Regulation of the human bilirubin UDP-glucuronosyltransferase gene. Adv. Enzyme Regul. 1996; 36: 85-97.
8. Lee Y-H, Sauer B, Johnson PF, Gonzalez FJ. Disruption of the c/ebpα gene in adult mouse liver. Mol. Cell Biol. 1997; 17: 6014-22.
9. Bosma PJ, Goldhoorn B, Bakker C et al. Presence of an additional TA in the TATA box of B-UGT correlates with Gilbert's syndrome. Hepatology 1995; 20: 226A. (Abstract).
10. Bosma PJ, Chowdhury RJ, Bakker C et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 1995; 333: 1171-5.
11. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347: 578-81.
12. Monaghan G, Foster B, Jurima-Romet M, Hume R, Burchell B. UGT1*1 genotyping in a Canadian Inuit population. Pharmacogenetics 1997; 7: 153-6.
13. Ideo G, De Franchis R, Del Ninno E, Dioguardi N. Ethanol increases liver uridine-diphosphate-glucuronosyltransferase. Experientia 1971; 27: 24-5.
14. Sampietro M, Lupica L, Pettero L, Romano R, Molteni V, Fionelli G. TATA-box promoter mutant in the promoter of UDP-glucuronosyltransferase gene in Italian patients with Gilbert's syndrome. Ital. J. Gastroenterol. Hepatol. 1998; 30: 194-8.
15. Beutler E, Gelbert T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT2A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism. Proc. Natl Acad. Sci. USA 1998; 95: 8170-4.
16. Ando Y, Chida M, Kazuo N, Saka H, Kamataki T. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 1998; 8: 357-60.
17. Koiwai O, Nishizawa M, Hasada K et al. Gilbert's syndrome is caused by heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum. Mol. Gen. 1995; 4: 1183-6.
18. Sato H, Adachi Y, Koiwai O. The genetic basis of Gilbert's syndrome. Lancet 1996; 347: 557-8.
19. Akaba K, Kimura T, Sasaki A et al. Neonatal hyperbilirubinaemia and mutation of bilirubin UDP-glucuronosyltransferase gene: A common missense mutation among Japanese, Koreans and Chinese. Biochem. Mol. Biol. Int. 1998; 46: 21-6.
20. Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP-glucuronosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochem. Biophys. Acta 1998; 1406: 267-73.
21. Aono S, Adachi Y, Uyama E et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 1995; 345: 958-9.
22. Chowdhury RJ, Wolkoff A, Chowdhury RN, Arias IM. Hereditary jaundice and disorders of bilirubin metabolism. In: Scriver CR, Beaudet A, Sly W and Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1995; 2161-208.
23. Onishi S, Kawade N, Itoh S, Isobe K, Sugiyama S. Postnatal development of uridine diphosphate glucuronosyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem. J. 1979; 184: 705-7.
24. Arias IM, Gartner LM, Seifter S, Furman M. Prolonged neonatal unconjugated hyperbilirubinaemia associated with breast-feeding and a steroid, pregnane-3α,20β-diol in maternal milk that inhibits glucuronide formation in vitro. J. Clin. Invest. 1964; 43: 2037-47.
25. Winfield CR, MacFaul R. Clinical study of prolonged jaundice in breast and bottle-fed babies. Arch. Dis. Child. 1978; 54: 506-7.
26. Osborn LM, Reiff MI, Bolus R. Jaundice in the full-term neonate. Pediatrics 1984; 73: 520-5.
27. Maisels MK, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: A new approach to an old problem. Pediatrics 1988; 81: 505-11.
28. Maisels MJ, Gifford K. Neonatal jaundice in full-term infants: Role of breast-feeding and other causes. Am. J. Dis. Child. 1983; 137: 561-2.
29. Bancroft JD, Kreamer B, Gourley GR. Gilbert syndrome accelerates development of neonatal jaundice. J. Paediatr. 1998; 132: 656-60.
30. Monaghan G, McLellan A, McGeechan A et al. Gilbert's syndrome is a contributory factor in very prolonged unconjugated hyperbilirubinaemia of the newborn. J. Pediatr. 1999; (in press).
31. Saland J, McNamara H, Cohen MI. Navajo jaundice: A variant of neonatal hyperbilirubinaemia associated with breast-feeding. J. Pediatr. 1974; 85: 271-5.
32. Fisher Q, Cohen MI, Curda L. Jaundice and breast-feeding among Alaska Eskimo newborns. Am. J. Dis. Child. 1978; 132: 859-63.
33. Johnson JD. Jaundice in Navajo neonates. Clin. Paediatr. 1992; 12: 716-18.
34. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency. A dose-dependent genetic interaction crucial to neonatal hyperbilirubinaemia. Proc. Natl Acad. Sci. USA 1997; 94: 12128-32.
35. Iolascon A, Faienza MF, Moretti A, Perotta S, Miraglia del Giudice E. UGT promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis. Blood 1998; 91: 1093.
36. Sanpietro M, Lupica L, Perrero L et al. The expression of UDP-glucuronosyltransferase is a major determinant of bilirubin level in heterozygous β-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency. Br. J. Haematol. 1997; 99: 437-9.
37. Ullrich D, Sieg A, Blume R, Bock KW, Schrotter W, Bircher J. Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur. J. Clin. Invest. 1987; 17: 237-40.
38. Macklon AF, Savage RL, Rawlins MD. Gilbert's syndrome and drug metabolism. Clin. Pharmacokinet. 1979; 4: 223-32.
39. De Morais SMF, Utetrecht JP, Wells PG. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 1992; 102: 577-86.
40. Bock KW, Forster A, Gschaidmeier H et al. Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferase. Biochem. Pharmacol. 1993; 45: 1809-14.
41. Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate-specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J. 1994; 303: 233-40.
42. King CD, Green MD, Rios GR et al. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch. Biochem. Biophys. 1996; 332: 92-100.
43. Wasserman E, Myara A, Lokiec F et al. Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports. Ann. Oncol. 1997; 810: 1049-51.
44. Gupta E, Mick R, Ramirez J et al. Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients. J. Clin. Oncol. 1997; 15: 1502-10.
45. Saliba F, Higipantelli R, Misset JL et al. Pathophysiology and therapy of irinotecan-induced onset diarrhoea in patients with advanced colorectal cancer. J. Clin. Oncol. 1998; 16: 2745-51.
46. Iyer L, King CD, Whitington PF et al. Genetic predisposition to the metabolism of irinotecan (CPT11). J. Clin. Invest. 1998; 101: 847-54.
47. Ando Y, Saka H, Asai G, Suriura S, Shimokata K, Kamataki T. UGT1Al1 genotypes and glucuronidation of SN38, the active metabolite of irinotecan. Ann. Oncol. 1998; 9: 845-7.